Urinary System Adenocarcinoma — Trials

Urinary System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 378
Recruiting: 193
Ph III recruiting: 14
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (279)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05733715	Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma	recruiting	Early Phase 1	30	Abramson Cancer Center at Penn MedicineOTHER	1	Aug 13, 2026	clinicaltrials
NCT07671417	Imaging Study in Metastatic Clear Cell RCC.	not yet recruiting	Early Phase 1	10	RayzeBio, Inc.INDUSTRY	1	Jul 16, 2026	clinicaltrials
NCT02210117